This federal contract award, valued at $1,223.59, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the product "4566748315 ! XDEMVY 0.25% DROP 10ML" and has a Firm Fixed Price pricing type with a completion date of January 9, 2025.
Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. Additionally, Amerisourcebergen maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.
The contract award reviewed does not have a set-aside designation, indicating open competition. As a major distributor of pharmaceutical and medical products to federal agencies, Amerisourcebergen plays a critical role in supplying essential medical supplies and treatments to military treatment facilities, veterans' healthcare programs, and other federal medical institutions.
Generated 3/18/25, 9:43 AM